Health Care Insider Trading Activity
Over the last 30 days, corporate insiders across 508 Health Care companies filed 308 purchases totaling $307.01M and 1,898 sales totaling $2.69B. The most-active Health Care companies by insider filings are listed below.
Most-active companies
200Showing companies 51 to 100 of 200 by distinct insiders filing.
| # | Ticker / Company | Insiders (30d) | Insider buys (30d) |
|---|---|---|---|
| 51 |  $ILMN ILLUMINA, INC. | 4 | - |
| 52 |  $LFST LifeStance Health Group, Inc. | 4 | - |
| 53 |  $PACS PACS Group, Inc. | 4 | - |
| 54 |  $CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 4 | - |
| 55 |  $JNJ JOHNSON & JOHNSON | 4 | - |
| 56 |  $TENX TENAX THERAPEUTICS, INC. | 4 | $4.93M |
| 57 |  $INBX Inhibrx Biosciences, Inc. | 4 | $4.00M |
| 58 |  $NAMS NewAmsterdam Pharma Co N.V. | 4 | $227K |
| 59 |  $MAZE Maze Therapeutics, Inc. | 4 | - |
| 60 |  $REGN REGENERON PHARMACEUTICALS, INC. | 4 | - |
| 61 |  $OMER OMEROS CORP | 4 | - |
| 62 |  $KURA Kura Oncology, Inc. | 4 | $1.24M |
| 63 |  $CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | 4 | - |
| 64 |  $ELAN Elanco Animal Health Inc | 4 | $936K |
| 65 |  $ANTX AN2 Therapeutics, Inc. | 4 | $12K |
| 66 |  $OBIO Orchestra BioMed Holdings, Inc. | 4 | $59K |
| 67 |  $BIVI BIOVIE INC. | 4 | $49K |
| 68 |  $PHIO Phio Pharmaceuticals Corp. | 4 | $40K |
| 69 |  $MGX Metagenomi Therapeutics, Inc. | 4 | $23K |
| 70 |  $EXOZ EXOZYMES INC. | 4 | $6K |
| 71 |  $SYK STRYKER CORP | 3 | $27K |
| 72 |  $UTHR UNITED THERAPEUTICS Corp | 3 | - |
| 73 |  $KIDS ORTHOPEDIATRICS CORP | 3 | - |
| 74 |  $ABT ABBOTT LABORATORIES | 3 | - |
| 75 |  $MRNA Moderna, Inc. | 3 | - |
| 76 |  $HALO HALOZYME THERAPEUTICS, INC. | 3 | - |
| 77 |  $ETON Eton Pharmaceuticals, Inc. | 3 | - |
| 78 |  $ONC BeOne Medicines Ltd. | 3 | - |
| 79 |  $HTFL Heartflow, Inc. | 3 | - |
| 80 |  $MIRM Mirum Pharmaceuticals, Inc. | 3 | - |
| 81 |  $IRON Disc Medicine, Inc. | 3 | - |
| 82 |  $SYRE Spyre Therapeutics, Inc. | 3 | - |
| 83 |  $PVLA PALVELLA THERAPEUTICS, INC. | 3 | - |
| 84 |  $TAK TAKEDA PHARMACEUTICAL CO LTD | 3 | - |
| 85 |  $CADL Candel Therapeutics, Inc. | 3 | - |
| 86 |  $URGN UroGen Pharma Ltd. | 3 | - |
| 87 |  $CSTL CASTLE BIOSCIENCES INC | 3 | - |
| 88 |  $SIBN SI-BONE, Inc. | 3 | - |
| 89 |  $CAMP Camp4 Therapeutics Corp | 3 | $40K |
| 90 |  $COO COOPER COMPANIES, INC. | 3 | $1.88M |
| 91 |  $KMDA KAMADA LTD | 3 | - |
| 92 |  $MNPR Monopar Therapeutics | 3 | - |
| 93 |  $JUSH Jushi Holdings Inc. | 3 | $1.10M |
| 94 |  $RGNX REGENXBIO Inc. | 3 | $949K |
| 95 |  $NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | 3 | $544K |
| 96 |  $NATR NATURES SUNSHINE PRODUCTS INC | 3 | $294K |
| 97 |  $MOBI Mobia Medical, Inc. | 3 | $219K |
| 98 |  $CTSO Cytosorbents Corp | 3 | $120K |
| 99 |  $LFVN Lifevantage Corp | 3 | $6K |
| 100 |  $PETV PetVivo Holdings, Inc. | 3 | $40K |
Industries in this sector
10- Pharmaceutical Preparations - 212 companies
- Biological Products, (No Diagnostic Substances) - 77 companies
- Surgical & Medical Instruments & Apparatus - 72 companies
- Laboratory Analytical Instruments - 18 companies
- Services-Medical Laboratories - 18 companies
- Orthopedic, Prosthetic & Surgical Appliances & Supplies - 17 companies
- Electromedical & Electrotherapeutic Apparatus - 16 companies
- Medicinal Chemicals & Botanical Products - 10 companies
- Hospital & Medical Service Plans - 9 companies
- In Vitro & In Vivo Diagnostic Substances - 8 companies
Reading a sector
Sales normally dwarf purchases here, and that is the baseline rather than a warning. Executives are paid in stock and sell to diversify or to cover the tax due when awards vest, so a large sell total across a sector usually reflects a vesting calendar. Buying is the informative side, because an insider purchasing on the open market is spending their own money on a company they already understand.
Companies are ranked by distinct insiders filing rather than by dollar value, which surfaces the cluster case: several people inside the same business acting in the same window. Where a company reports only an SEC SIC code, it is mapped into these sectors through a standard crosswalk, so the grouping reflects what a business does rather than how it happens to file.